MicroRNA-146b-3p regulates retinal inflammation by suppressing adenosine deaminase-2 in diabetes

Area of Science:

• Ophthalmology
• Immunology
• Molecular Biology

Background:

• Diabetic retinopathy (DR) involves inflammation triggered by hyperglycemia and Amadori-glycated albumin (AGA), activating microglia and monocytes.
• Early DR detection is crucial to prevent irreversible tissue damage.
• Adenosine, an anti-inflammatory molecule, is regulated by equilibrative nucleoside transporter, adenosine deaminase (ADA), and adenosine kinase.

Purpose of the Study:

• To investigate the role of miR-146b-3p in regulating adenosine deaminase 2 (ADA2) and its impact on inflammation in diabetic retinopathy.
• To clarify the mechanism of adenosine-dependent anti-inflammation in diabetes, particularly concerning ADA2.

Main Methods:

• Analysis of miR-146b-3p binding sites in the 3'-UTR of ADA2 mRNA using database searches.
• Reporter gene assays to confirm the regulatory effect of miR-146b-3p on ADA2 expression.
• Measurement of miR-146b-3p levels and ADA2 activity in the vitreous of diabetic patients.
• Experimental manipulation of miR-146b-3p expression in AGA-treated human macrophages to assess its effect on ADA2 and TNF-α.

Main Results:

• miR-146b-3p was identified as a regulator of ADA2 expression.
• Decreased miR-146b-3p levels in the vitreous of diabetic patients were associated with increased ADA2 activity.
• Ectopic expression of miR-146b-3p in macrophages suppressed ADA2 expression, activity, and TNF-α release.

Conclusions:

• miR-146b-3p plays a significant role in suppressing ADA2, thereby modulating inflammation in the context of diabetes.
• The miR-146b-3p/ADA2 axis represents a potential pathway for therapeutic intervention in diabetic retinopathy.